Delirium resolving upon switching from risperidone to quetiapine: implication of CYP2D6 genotype.
Kato
Daiji
D
Kawanishi
Chiaki
C
Kishida
Ikuko
I
Furuno
Taku
T
Matsumura
Takehiko
T
Hasegawa
Hana
H
Hirayasu
Yoshio
Y
D000368:Aged; D000544:Alzheimer Disease / Q000150:complications*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D003693:Delirium / Q000139:chemically induced* / Q000188:drug therapy*; D003987:Dibenzothiazepines / Q000627:therapeutic use*; D005838:Genotype; D006801:Humans; D008297:Male; D000069348:Quetiapine Fumarate; D018967:Risperidone / Q000009:adverse effects*
D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D019389:Cytochrome P-450 CYP2D6; D018967:Risperidone